Evidence map›Paper›PMID 39684805›Full record

ReviewInternational journal of molecular sciences2024

Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications.

Chiara Siracusa, Nicole Carabetta, Maria Benedetta Morano, Marzia Manica, Antonio Strangio, Jolanda Sabatino, Isabella Leo, Alberto Castagna, Eleonora Cianflone, Daniele Torella and 6 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Effects of Progressive Inspiratory Muscle Training on Lung Volume and Respiratory Strength in Patients With Pre-Dialysis Chronic Kidney Disease.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2026
    Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Mineralocorticoid Receptor Antagonists in Dialysis.American journal of nephrology · 2026
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chiara SiracusaDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
Nicole CarabettaDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
Maria Benedetta MoranoDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
Marzia ManicaDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
Antonio StrangioDepartment of Experimental and Clinical Medicine, "Magna Grecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-2832-8150
Jolanda SabatinoDepartment of Experimental and Clinical Medicine, "Magna Grecia" University, 88100 Catanzaro, Italy.
Isabella LeoDepartment of Experimental and Clinical Medicine, "Magna Grecia" University, 88100 Catanzaro, Italy.
Alberto CastagnaDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
Eleonora CianfloneDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-1675-2093
Daniele TorellaDepartment of Experimental and Clinical Medicine, "Magna Grecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-4915-5084
Michele AndreucciDepartment of Health Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-7974-3792
Maria Teresa ZicarelliDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
Michela MusolinoDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
Davide BolignanoDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.ORCID 0000-0003-3032-245X
Giuseppe CoppolinoDepartment of Health Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.ORCID 0000-0001-8000-0681
Salvatore De RosaDepartment of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.ORCID 0000-0001-5388-942X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular calcification (VC) is a biological phenomenon characterized by an accumulation of calcium and phosphate deposits within the walls of blood vessels causing the loss of elasticity of the arterial walls. VC plays a crucial role in the incidence and progression of chronic kidney disease (CKD), leading to a significant increase in cardiovascular mortality in these patients. Different conditions such as age, sex, dyslipidemia, diabetes, and hypertension are the main risk factors in patients affected by chronic kidney disease. However, VC may occur earlier and faster in these patients if it is associated with new or non-traditional risk factors such as oxidative stress, anemia, and inflammation. In chronic kidney disease, several pathophysiological processes contribute to vascular calcifications, including osteochondrogenic differentiation of vascular cells, hyperphosphatemia and hypercalcemia, and the loss of specific vascular calcification inhibitors including pyrophosphate, fetuin-A, osteoprotegerin, and matrix GLA protein. In this review we discuss the main traditional and non-traditional risk factors that can promote VC in patients with kidney disease. In addition, we provide an overview of the main pathogenetic mechanisms responsible for VC that may be crucial to identify new prevention strategies and possible new therapeutic approaches to reduce cardiovascular risk in patients with kidney disease.

Indexed as

Renal Insufficiency, ChronicVascular Calcificationalpha-2-HS-GlycoproteinAnimalsHumansOsteoprotegerinOxidative StressRisk Factorsalpha-2-HS-GlycoproteinOsteoprotegerinaortic stenosiscardiovascular riskchronic kidney diseaseprecision medicinevascular calcification

Identifiers

PMID39684805
PMCPMC11642360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.